Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A12 | Q96S37 | 3/20 | 0.54 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.46 |
| ▸ | AR | P10275 | 2/20 | 0.45 |
| ▸ | CNR2 | P34972 | 1/20 | 0.44 |
| ▸ | RORC | P51449 | 1/20 | 0.44 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.43 |
| ▸ | PGR | P06401 | 1/20 | 0.43 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.42 |
| ▸ | RXRA | P19793 | 1/20 | 0.42 |
| ▸ | RXRB | P28702 | 1/20 | 0.42 |
| ▸ | RXRG | P48443 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20187001 | 0.89 | SLC22A12 (0.55) | SLC22A12ARCNR2RORCIMPDH2 | |
| SCHEMBL20186971 | 0.88 | SLC22A12 (0.54) | SLC22A12ARCNR2RORCIMPDH2 | |
| SCHEMBL20186980 | 0.88 | SLC22A12 (0.54) | SLC22A12PLA2G7ARCNR2RORC | |
| SCHEMBL20186990 | 0.84 | RORC (0.51) | SLC22A12PLA2G7ARCNR2RORC | |
| SCHEMBL14285996 | 0.78 | SLC22A12 (0.56) | SLC22A12PLA2G7ARCNR2PGR | |
| SCHEMBL20186965 | 0.76 | RORC (0.48) | SLC22A12RORCIMPDH2PGR | |
| SCHEMBL20186961 | 0.74 | FFAR4 (0.67) | ARRORCFFAR4 | |
| SCHEMBL20186962 | 0.74 | AR (0.42) | SLC22A12PLA2G7ARRORCIMPDH2 | |
| SCHEMBL20186964 | 0.71 | IMPDH2 (0.50) | SLC22A12ARRORCIMPDH2PGR | |
| SCHEMBL110567 | 0.71 | AR (0.56) | ARPGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10905120-B2 | ABA receptor agonists that modulate transpiration | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-02-02 | — | — | US | disclosed |
| US-20180146666-A1 | ABA RECEPTOR AGONISTS THAT MODULATE TRANSPIRATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2018-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10905120-B2 | ABA receptor agonists that modulate transpiration | ADORA2A, ADORA1, AAK1 | SLC22A12 930/4885PLA2G7 1724/4885AR 1334/4885 |
| US-20180146666-A1 | ABA RECEPTOR AGONISTS THAT MODULATE TRANSPIRATION | ADORA2A, ADORA1, AAK1 | SLC22A12 930/4885PLA2G7 1724/4885AR 1334/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.